Skip to Main Content

Paper Details

Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.
JAMA
102
2019
Crohn disease, IBD, Inflammatory Bowel Disease, Myelosuppression, NUDT15, NUDT15 variants, Participants, Patients, TIM, TPMT, TPMT genotype, Thiopurine, chromosome 13, chromosome 6, coding, inflammatory bowel disease, myelosuppression, neutrophil cell, patients, rs11969064, rs746071566, thiopurine, thiopurine-, thiopurines, white blood cell, women
Author NameAffiliation
Carl A AndersonWellcome Trust Sanger Institute
Ashwin N AnanthakrishnanMassachusetts General Hospital
Jeffrey C BarrettWellcome Trust Sanger Institute
Mark J DalyBroad Institute, Harvard University
Mark J DalyBroad Institute, Harvard University
Jonas HalfvarsonOrebro University
Dermot P B McGovernF. Widjaja Foundation Inflammatory Bowel Disease and Immunobiology Research Institute, Cedars-Sinai Medical Center
Dermot P B McGovernF. Widjaja Foundation Inflammatory Bowel Disease and Immunobiology Research Institute, Cedars-Sinai Medical Center
Manuel A RivasBroad Institute, Harvard University
Manuel A RivasBroad Institute, Harvard University
Harry SokolSaint-Antoine Hospital and Sorbonne Universite
Ramnik J XavierBroad Institute, Harvard University
Ramnik J XavierBroad Institute, Harvard University
Michael N WeedonUniversity of Exeter Medical School
  • 1 - 14

Datasets

Release 1.2